Evidence map›Paper›PMID 40890135›Full record

ArticleTranslational psychiatry2025

[

Sarah Chaib, Elise Levigoureux, Sandrine Bouvard, Caroline Bouillot, Benjamin Vidal, Anthony Fourier, Adrian Newman-Tancredi, Luc Zimmer

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah ChaibUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France.ORCID http://orcid.org/0000-0001-5874-6858
Elise LevigoureuxUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France.
Sandrine BouvardUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France.
Caroline BouillotCERMEP-Imaging Platform, Bron, France.
Benjamin VidalUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France.
Anthony FourierUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France.
Adrian Newman-TancrediNeurolixis, Castres, France.ORCID http://orcid.org/0000-0002-2923-5714
Luc ZimmerUniversité Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS, INSERM, Lyon, France. luc.zimmer@univ-lyon1.fr.ORCID http://orcid.org/0000-0002-2805-7098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid-acting antidepressants (RAADs) such as ketamine are currently under development. The aim of this study is to characterize the neural circuits affected by ketamine and NLX-101, a selective 5-HT

Indexed as

Antidepressive AgentsBrainDepressionKetaminePiperazinesSerotonin 5-HT1 Receptor AgonistsAnimalsAnxietyCorticosteroneDisease Models, AnimalFluorodeoxyglucose F18MalePositron-Emission TomographyPyridinesRadiopharmaceuticalsRatsAntidepressive AgentsCorticosteroneFluorodeoxyglucose F18KetamineN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamidePiperazinesPyridinesRadiopharmaceuticalsReceptor, Serotonin, 5-HT1ASerotonin 5-HT1 Receptor Agonists

Identifiers

PMID40890135
PMCPMC12402087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.